Physician Assistant Program year 2025 Reported 2024–2025 Source: CMS Open Payments, 2026 publication

Johnathon Tucker

Physician Assistant Charleston, SC Physician Assistant

NPI 1912767674 CMS profile 11578684

4 Carriage Ln Ste 200, Charleston, SC 29407

Open in the dashboard

General payments

$7,475

299 records reported · program years 2024–2025

Research payments

$0

Paid to them · None reported · program years 2024–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Johnathon Tucker of Charleston, SC is reported in the CMS Open Payments database as having received $7,475 across 299 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 95th percentile of Physician Assistant profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

2 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,339 171
2024 General $3,136 128

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Johnathon Tucker
  • Physician Assistant median
  • Middle half of Physician Assistant
  • National median

In program year 2025, general payments to Johnathon Tucker were reported at $4,339. Among 68,903 Physician Assistant profiles paid that year, the median was $184 and the middle half received between $57 and $620.

Show as a table
Year Johnathon Tucker Physician Assistant median Middle half National median
2019 $0 $34 $17–$122 $163
2020 $0 $33 $16–$78 $114
2021 $0 $132 $37–$438 $132
2022 $0 $155 $48–$522 $149
2023 $0 $167 $52–$557 $160
2024 $3,136 $178 $55–$600 $164
2025 $4,339 $184 $57–$620 $169

Breakdown

Who paid General payments · program years 2024–2025
  1. Vanda Pharmaceuticals Inc. $964 32 payments
  2. AbbVie, Inc. $763 51 payments
  3. ITI, Inc. $733 29 payments
  4. Otsuka America Pharmaceutical, Inc. $733 28 payments
  5. Teva Pharmaceuticals USA, Inc. $514 22 payments
  6. Neurocrine Biosciences, Inc. $438 13 payments
  7. Axsome Therapeutics, Inc. $376 14 payments
  8. Takeda Pharmaceuticals U.S.A., Inc. $358 12 payments
  9. Janssen Pharmaceuticals, Inc $350 14 payments
  10. Alkermes, Inc. $334 8 payments
  11. Other $1,912 76 payments

Every payment, record by record

What the payments were for General payments · program years 2024–2025
  1. Food and Beverage $7,396 298 payments
  2. Education $80 1 payment
Products named General payments · program years 2024–2025
  1. FANAPT $964 32 payments
  2. HETLIOZ $637 29 payments
  3. REXULTI $577 24 payments
  4. CAPLYTA $503 18 payments
  5. VRAYLAR $500 29 payments
  6. INGREZZA $438 13 payments
  7. Auvelity $376 14 payments
  8. TRINTELLIX $358 12 payments
  9. SPRAVATO $350 14 payments
  10. Azstarys $308 14 payments
  11. Other $4,280 155 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

299 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Physician Assistant in South Carolina

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record